Rexahn Pharmaceuticals Regains Compliance with NYSE Amex Listing Requirements |
 |
 |
| Wednesday, 08 July 2009 16:10 |
 Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a leader in innovative therapeutics for life-threatening and life-debilitating diseases, today announced that on July 7, 2009, the Company received a notice from NYSE Amex, formerly known as the American Stock Exchange (the “Exchange”), indicating that it had regained compliance with the requirements of the NYSE Amex Company Guide for the continued listing of its common stock on the Exchange, and that its common stock therefore was no longer subject to delisting.
About Rexahn Pharmaceuticals, Inc. Rexahn Pharmaceuticals is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn’s compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain their quality of life. For Additional information about Rexahn visit www.rexahn.com BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section Add this page to your favorite Social Bookmarking websites            |
about 15 minutes ago
Ampio Pharmaceuticals (AMPE): Positioned For A Rebound - Small Cap Stock Market Investing Tips http://t.co/HmPlIyS9
about 58 minutes ago
$AMLN Said to Attract Interest From Pfizer, AstraZeneca - Businessweek http://t.co/PFKT6LE8
about 1 hour ago
Stock Market: Stocks Extend Losing Streak http://t.co/ZmZxvJiO
about 3 hours ago
Cancer Survivors Who Exercise Live Longer http://t.co/U4MhX04a
about 4 hours ago
Colon cancer screenings that don’t require laxatives are almost as effective as colonoscopies and may encourage more tests http://j.m…
about 4 hours ago
Testing a Drug That May Stop Alzheimer’s Before It Starts $RHHBY http://t.co/Wjgw15IS
about 5 hours ago
Two patients get eye stem cells transplanted to restore sight http://t.co/HHYZlFFT
about 5 hours ago
US Senate call to scrap drug patents: http://t.co/W1BOuxJp
Free Phone Trade Alerts
